Glycomics/ Glycobiology Market

Glycomics/ Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027

Report Code: BT 2776 Nov, 2022, by marketsandmarkets.com

The glycomics/ glycobiology market size is projected to reach USD 3.7 billion by 2027, at a CAGR of 15.5% during the forecast period. Growth in the glycomics/glycobiology market can be attributed to factors such as the use of glycans as biomarkers, and increasing number of collaboration and partnership among players for improving glycomics research.

Growth Opportunities in the Glycomics/ Glycobiology Market

Glycomics/Glycobiology Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Glycomics/ Glycobiology Market Size, Share, Trends and Dynamics

Drivers: Emergence of glycans as biomarkers

Glycans play a vital role in biology; alterations in glycans can lead to dangerous consequences, such as congenital disorders, heart diseases, growth defects, and epilepsy. Research has shown that mutation in glycosyltransferases or related enzymes modifies/alters the glycome and can cause over 100 types of human congenital disorders of glycosylation.

Restraints: Extravagant cost of glycobiology products and tools

The high cost of glycobiology products and instruments like reagents, carbohydrates, mass spectrometers, glycan analysis kits, and enzymes pose an obstacle to their adoption. Developing glycobiology tools requires significant investment; stringent rules and regulations make them even more expensive.

Opportunities: Glycomics applications in precision medicine

Precision medicine has grown rapidly in the last few years. Many pharma and biotech companies are investing heavily to develop targeted drugs that can be used for a specific group of patients. Sugars present on the surface of the cells and complex biomolecules are involved in various processes, including cell recognition and communication. These are crucial processes in inflammation, autoimmune disease, and viral & bacterial infections.

Challenges: Lack of skilled workforce

One of the biggest challenges is the lack of skilled workforce engaged in glycobiology research and conduct the process. This is very time consuming, cost ineffective and risky process. Even the staff who handles the glycobiology products are present in scarce. This factor is a biggest obstacle in the market.

The enzyme segment is projected to hold the dominant position during the forecast period:

On the bases on product, the global glycomics/glycobiology market is segmented into enzymes, instruments, kits, carbohydrates, and reagents and chemicals. The enzyme segment is expected to remain dominant by 2027 owing to consumable nature of enzymes and increasing use of enzymes in glycan analysis.

North America was the largest regional market for glycomics/glycobiology market in 2021.

The market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market, and this trend is expected to continue during the forecast period. The increasing investments by companies in glycomics research and development and the presence of prominent market players in the US.

Glycomics/Glycobiology Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Glycomics/ Glycobiology Market - Key Players

Key players in the market include Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US).

Scope of the Glycomics/ Glycobiology Market Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, Application and End User

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Companies covered

Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain), and Ray Biotech Life Inc. (US).

This report categorizes the glycomics/ glycobiology market into the following segments and subsegments

Glycomics/ Glycobiology Market, By Product

  • Enzymes
    • Glycosidases
    • Transferases
    • Other Enzymes
  • Instruments
  • Kits
    • Glycan Releasing Kits
    • Glycan Purification Kits
    • Glycan Labeling Kits
    • Other Kits
  • Carbohydrates
    • Oligosaccharides
    • Polysaccharides
    • Other Carbohydrates
  • Reagents & Chemicals

Glycomics/ Glycobiology Market, By Application

  • Drug Discovery & Development
  • Diagnostics
  • Cancer Diagnostics
  • Other Diagnostics
  • Other Applications

Glycomics/ Glycobiology Market, By End User

Glycomics/ Glycobiology Market, By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In April 2022, Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
  • In April 2021, GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
    1.6 LIMITATIONS
    1.7 STAKEHOLDERS
    1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 43)
    2.1 RESEARCH APPROACH
          FIGURE 1 RESEARCH DESIGN
           2.1.1 PRIMARY RESEARCH
                    FIGURE 2 GLYCOMICS/GLYCOBIOLOGY MARKET: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY
          FIGURE 3 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
          FIGURE 6 GLYCOMICS/GLYCOBIOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 52)
FIGURE 8 GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 10 GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF GLYCOMICS/GLYCOBIOLOGY MARKET

4 PREMIUM INSIGHTS (Page No. - 56)
    4.1 GLYCOMICS/GLYCOBIOLOGY MARKET OVERVIEW
          FIGURE 12 RISING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
    4.2 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT 
          FIGURE 13 ENZYMES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.3 GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY PRODUCT, 2022 VS. 2027
          FIGURE 14 ENZYMES SEGMENT TO DOMINATE MARKET IN 2027
    4.4 GLYCOMICS/GLYCOBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 60)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 16 GLYCOMICS/GLYCOBIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 GLYCOMICS/GLYCOBIOLOGY MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Emergence of glycans as biomarkers
                    5.2.1.2 Technological advancements in glycan analysis
                    5.2.1.3 Increasing R&D expenditure and funding
                                FIGURE 17 R&D EXPENDITURE BY PHRMA MEMBER COMPANIES, 2001–2021 (USD BILLION)
                                TABLE 2 FUNDING FOR NIH INNOVATION PROJECTS UNDER 21ST CENTURY CURES ACT, 2017–2026
                    5.2.1.4 Collaborations and partnerships
                    5.2.1.5 Increasing number of cancer cases worldwide
                                FIGURE 18 NUMBER OF NEW CASES WORLDWIDE, 2020
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of glycobiology products and tools
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Glycomics applications in precision medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of skilled workforce
    5.3 RANGES/SCENARIOS
          FIGURE 19 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF GLYCOMICS/GLYCOBIOLOGY MARKET
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
          FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
    5.5 PRICING ANALYSIS
          TABLE 3 AVERAGE SELLING PRICES OF PRODUCTS OFFERED BY KEY PLAYERS
    5.6 TECHNOLOGY ANALYSIS
           5.6.1 CELL-FREE SYNTHETIC GLYCOBIOLOGY
           5.6.2 GLYCAN MICROARRAY PLATFORMS
           5.6.3 MASS SPECTROMETRY FOR GLYCOSAMINOGLYCANS
    5.7 VALUE CHAIN ANALYSIS
          FIGURE 21 VALUE CHAIN ANALYSIS OF GLYCOMICS/GLYCOBIOLOGY MARKET
    5.8 ECOSYSTEM ANALYSIS
          FIGURE 22 ECOSYSTEM ANALYSIS: GLYCOMICS/GLYCOBIOLOGY MARKET
          TABLE 4 SUPPLY CHAIN ECOSYSTEM
    5.9 KEY CONFERENCES AND EVENTS IN 2022–2023
          TABLE 5 GLYCOMICS/GLYCOBIOLOGY MARKET: LIST OF CONFERENCES AND EVENTS
    5.10 REGULATORY ANALYSIS
           5.10.1 NORTH AMERICA
           5.10.2 EUROPE
           5.10.3 EMERGING MARKETS
    5.11 PORTER’S FIVE FORCES ANALYSIS
           TABLE 6 GLYCOMICS/GLYCOBIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 THREAT OF NEW ENTRANTS
           5.11.2 THREAT OF SUBSTITUTES
           5.11.3 BARGAINING POWER OF BUYERS
           5.11.4 BARGAINING POWER OF SUPPLIERS
           5.11.5 DEGREE OF COMPETITION
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
           FIGURE 23 INFLUENCE OF STAKEHOLDERS ON PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN BUYING PROCESS OF GLYCOMICS/GLYCOBIOLOGY PRODUCTS
           FIGURE 24 BUYING CRITERIA FOR GLYCOMICS/GLYCOBIOLOGY PRODUCTS

6 GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT (Page No. - 75)
    6.1 INTRODUCTION
          TABLE 7 GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 ENZYMES
          TABLE 8 ENZYMES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 9 NORTH AMERICA: ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 10 EUROPE: ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 11 ASIA PACIFIC: ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 12 LATIN AMERICA: ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 13 ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.2.1 GLYCOSIDASES
                    6.2.1.1 Glycosidases to hold largest share of enzymes market
                                TABLE 14 GLYCOSIDASES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 15 NORTH AMERICA: GLYCOSIDASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 16 EUROPE: GLYCOSIDASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 17 ASIA PACIFIC: GLYCOSIDASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 18 LATIN AMERICA: GLYCOSIDASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 TRANSFERASES
                    6.2.2.1 Transferase catalyzes transfer of specific functional groups
                                TABLE 19 TRANSFERASES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 20 NORTH AMERICA: TRANSFERASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 21 EUROPE: TRANSFERASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 22 ASIA PACIFIC: TRANSFERASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 23 LATIN AMERICA: TRANSFERASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 OTHER ENZYMES
                    TABLE 24 OTHER ENZYMES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 25 NORTH AMERICA: OTHER ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 26 EUROPE: OTHER ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 27 ASIA PACIFIC: OTHER ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 28 LATIN AMERICA: OTHER ENZYMES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 KITS
          TABLE 29 KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 30 NORTH AMERICA: KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 31 EUROPE: KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 32 ASIA PACIFIC: KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 33 LATIN AMERICA: KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 34 KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.3.1 GLYCAN RELEASING KITS
                    6.3.1.1 Separation of glycans from glycoproteins is the foremost step in glycomics
                                TABLE 35 GLYCAN RELEASING KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 36 NORTH AMERICA: GLYCAN RELEASING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 37 EUROPE: GLYCAN RELEASING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 38 ASIA PACIFIC: GLYCAN RELEASING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 39 LATIN AMERICA: GLYCAN RELEASING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.2 GLYCAN LABELING KITS
                    6.3.2.1 Advancements in labeling kits to drive market growth
                                TABLE 40 GLYCAN LABELING KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 41 NORTH AMERICA: GLYCAN LABELING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 42 EUROPE: GLYCAN LABELING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: GLYCAN LABELING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 44 LATIN AMERICA: GLYCAN LABELING KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.3 GLYCAN PURIFICATION KITS
                    6.3.3.1 Need to separate unwanted material from samples for better characterization to drive use of purification kits
                                TABLE 45 GLYCAN PURIFICATION KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 46 NORTH AMERICA: GLYCAN PURIFICATION KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 47 EUROPE: GLYCAN PURIFICATION KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 48 ASIA PACIFIC: GLYCAN PURIFICATION KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 49 LATIN AMERICA: GLYCAN PURIFICATION KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.4 OTHER KITS
                    TABLE 50 OTHER KITS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 51 NORTH AMERICA: OTHER KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 52 EUROPE: OTHER KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 53 ASIA PACIFIC: OTHER KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 54 LATIN AMERICA: OTHER KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 REAGENTS & CHEMICALS
           6.4.1 GROWING DEMAND FOR REAGENTS & CHEMICALS TO DRIVE MARKET GROWTH
                    TABLE 55 REAGENTS & CHEMICALS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 56 NORTH AMERICA: REAGENTS & CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 57 EUROPE: REAGENTS & CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 58 ASIA PACIFIC: REAGENTS & CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 59 LATIN AMERICA: REAGENTS & CHEMICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 CARBOHYDRATES
          TABLE 60 CARBOHYDRATES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 61 NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 62 EUROPE: CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 63 ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 64 LATIN AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 65 CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.5.1 OLIGOSACCHARIDES
                    6.5.1.1 Oligosaccharides to dominate carbohydrates segment
                                TABLE 66 OLIGOSACCHARIDES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 67 NORTH AMERICA: OLIGOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 68 EUROPE: OLIGOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 69 ASIA PACIFIC: OLIGOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 70 LATIN AMERICA: OLIGOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.2 MONOSACCHARIDES
                    6.5.2.1 Growing use in solution/buffer preparation to drive market
                                TABLE 71 MONOSACCHARIDES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 72 NORTH AMERICA: MONOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 73 EUROPE: MONOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 74 ASIA PACIFIC: MONOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 75 LATIN AMERICA: MONOSACCHARIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.3 OTHER CARBOHYDRATES
                    TABLE 76 OTHER CARBOHYDRATES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 77 NORTH AMERICA: OTHER CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 78 EUROPE: OTHER CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: OTHER CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 80 LATIN AMERICA: OTHER CARBOHYDRATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 INSTRUMENTS
          TABLE 81 INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 82 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 83 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 84 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 85 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 86 INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.6.1 MASS SPECTROMETRY INSTRUMENTS
                    6.6.1.1 Wide use of mass spectrometry in glycan analysis to support segment growth
                                TABLE 87 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 88 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 89 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 90 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 91 LATIN AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.6.2 CHROMATOGRAPHY INSTRUMENTS
                    6.6.2.1 Need to separate unwanted material during glycan analysis to drive demand for chromatography instruments
                                TABLE 92 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 93 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 94 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 95 ASIA PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 96 LATIN AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.6.3 ARRAYS
                    6.6.3.1 Increasing demand for glycan, lectin, and antibody arrays to drive market growth
                                TABLE 97 ARRAYS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 98 NORTH AMERICA: ARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 99 EUROPE: ARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 100 ASIA PACIFIC: ARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 101 LATIN AMERICA: ARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.6.4 OTHER INSTRUMENTS
                    TABLE 102 OTHER INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 103 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 104 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 105 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 106 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION (Page No. - 127)
    7.1 INTRODUCTION
          TABLE 107 GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 DRUG DISCOVERY & DEVELOPMENT
           7.2.1 INCREASING IMPORTANCE OF GLYCAN ANALYSIS IN DRUG DEVELOPMENT TO DRIVE GROWTH
                    TABLE 108 GLYCOMICS/GLYCOBIOLOGY MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 109 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 110 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 111 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 112 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 DIAGNOSTICS
          TABLE 113 GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 114 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 115 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 116 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 117 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 118 GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
           7.3.1 CANCER DIAGNOSTICS
                    7.3.1.1 Rising importance of glycomics in cancer diagnostics to support market growth
                                TABLE 119 GLYCOMICS/GLYCOBIOLOGY MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 120 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 121 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 122 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 123 LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
           7.3.2 OTHER DIAGNOSTIC APPLICATIONS
                    TABLE 124 GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 125 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 126 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 127 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 128 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 OTHER APPLICATIONS
          TABLE 129 GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 130 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 131 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 132 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 133 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

8 GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER (Page No. - 143)
    8.1 INTRODUCTION
          TABLE 134 GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 ACADEMIC & RESEARCH INSTITUTES
           8.2.1 ACADEMIC & RESEARCH INSTITUTES TO ACCOUNT FOR LARGEST MARKET SHARE
                    TABLE 135 GLYCOMICS/GLYCOBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 136 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 137 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 139 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           8.3.1 INCREASING INTEREST IN DEVELOPING CARBOHYDRATE-BASED THERAPEUTICS TO DRIVE SEGMENT GROWTH
                    TABLE 140 GLYCOMICS/GLYCOBIOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 141 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 142 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 143 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 144 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 CLINICAL LABORATORIES
           8.4.1 RISING BURDEN OF INFECTIOUS DISEASE AND CANCER TO DRIVE MARKET GROWTH
                    TABLE 145 GLYCOMICS/GLYCOBIOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 146 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 147 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 148 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 149 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 CONTRACT RESEARCH ORGANIZATIONS
           8.5.1 RISING PREFERENCE FOR OUTSOURCING TO DRIVE MARKET GROWTH
                    TABLE 150 GLYCOMICS/GLYCOBIOLOGY MARKET FOR CROS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 151 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CROS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 152 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CROS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 153 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CROS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 154 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR CROS, BY COUNTRY, 2020–2027 (USD MILLION)

9 GLYCOMICS/GLYCOBIOLOGY MARKET, BY REGION (Page No. - 155)
    9.1 INTRODUCTION
          TABLE 155 GLYCOMICS/GLYCOBIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 25 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET SNAPSHOT
          TABLE 156 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 157 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 158 NORTH AMERICA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 159 NORTH AMERICA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 160 NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 161 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 162 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 163 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 164 NORTH AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US to hold largest share of glycomics/glycobiology market
                                TABLE 165 US: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 166 US: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 167 US: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 168 US: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 169 US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 170 US: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 171 US: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 172 US: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Increasing government funding and strong infrastructure to drive growth
                                TABLE 173 CANADA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 174 CANADA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 175 CANADA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 176 CANADA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 177 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 178 CANADA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 179 CANADA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 180 CANADA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.3 EUROPE
          TABLE 181 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 182 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 183 EUROPE: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 184 EUROPE: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 185 EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 186 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 187 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 188 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 189 EUROPE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany to dominate European glycomics/glycobiology market
                                TABLE 190 GERMANY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 191 GERMANY: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 192 GERMANY: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 193 GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 194 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 195 GERMANY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 196 GERMANY: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 197 GERMANY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Rising investments in pharmaceutical R&D to boost market growth
                                TABLE 198 UK: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 199 UK: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 200 UK: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 201 UK: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 202 UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 203 UK: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 204 UK: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 205 UK: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Well-established life sciences industry to support market growth
                                TABLE 206 FRANCE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 207 FRANCE: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 208 FRANCE: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 209 FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 210 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 211 FRANCE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 212 FRANCE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 213 FRANCE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increased funding and strong research base to drive market
                                TABLE 214 ITALY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 215 ITALY: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 216 ITALY: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 217 ITALY: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 218 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 219 ITALY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 220 ITALY: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 221 ITALY: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Government initiatives to expand pharma & biotech sector to support market growth
                                TABLE 222 SPAIN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 223 SPAIN: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 224 SPAIN: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 225 SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 226 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 227 SPAIN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 228 SPAIN: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 229 SPAIN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 230 ROE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 231 ROE: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 232 ROE: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 233 ROE: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 234 ROE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 235 ROE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 236 ROE: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 237 ROE: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 26 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET SNAPSHOT
          TABLE 238 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 239 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 240 ASIA PACIFIC: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 241 ASIA PACIFIC: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 242 ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 243 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 244 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 245 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 246 ASIA PACIFIC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China to hold largest share of APAC market
                                TABLE 247 CHINA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 248 CHINA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 249 CHINA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 250 CHINA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 251 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 252 CHINA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 253 CHINA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 254 CHINA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Research initiatives for precision medicine to boost market
                                TABLE 255 JAPAN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 256 JAPAN: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 257 JAPAN: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 258 JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 259 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 260 JAPAN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 261 JAPAN: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 262 JAPAN: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increased R&D activities to drive market growth
                                TABLE 263 INDIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 264 INDIA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 265 INDIA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 266 INDIA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 267 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 268 INDIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 269 INDIA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 270 INDIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Rising funding for research to support market growth
                                TABLE 271 AUSTRALIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 272 AUSTRALIA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 273 AUSTRALIA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 274 AUSTRALIA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 275 AUSTRALIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 276 AUSTRALIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 277 AUSTRALIA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 278 AUSTRALIA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 279 ROAPAC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 280 ROAPAC: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 281 ROAPAC: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 282 ROAPAC: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 283 ROAPAC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 284 ROAPAC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 285 ROAPAC: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 286 ROAPAC: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA
          TABLE 287 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 288 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 289 LATIN AMERICA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 290 LATIN AMERICA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 291 LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 292 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 293 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 294 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 295 LATIN AMERICA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Brazil to hold largest share of Latin American market
                                TABLE 296 BRAZIL: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 297 BRAZIL: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 298 BRAZIL: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 299 BRAZIL: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 300 BRAZIL: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 301 BRAZIL: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 302 BRAZIL: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 303 BRAZIL: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Well-built pharmaceutical industry to support market growth
                                TABLE 304 MEXICO: CANCER CASES, BY CANCER TYPE, 2020
                                TABLE 305 MEXICO: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 306 MEXICO: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 307 MEXICO: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 308 MEXICO: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 309 MEXICO: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 310 MEXICO: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 311 MEXICO: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 312 MEXICO: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 313 ROLATAM: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 314 ROLATAM: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 315 ROLATAM: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 316 ROLATAM: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 317 ROLATAM: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 318 ROLATAM: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 319 ROLATAM: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 320 ROLATAM: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 INCREASED FOCUS ON PRECISION MEDICINE AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
                    TABLE 321 MEA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 322 MEA: ENZYMES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 323 MEA: KITS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 324 MEA: CARBOHYDRATES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 325 MEA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 326 MEA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 327 MEA: GLYCOMICS/GLYCOBIOLOGY MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 328 MEA: GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 242)
     10.1 INTRODUCTION
     10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
             FIGURE 27 GLYCOMICS/GLYCOBIOLOGY MARKET: STRATEGIES ADOPTED
     10.3 MARKET SHARE ANALYSIS
             FIGURE 28 GLYCOMICS/GLYCOBIOLOGY MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
             TABLE 329 GLYCOMICS/GLYCOBIOLOGY MARKET: DEGREE OF COMPETITION
     10.4 REVENUE ANALYSIS
             FIGURE 29 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 30 GLYCOMICS/GLYCOBIOLOGY MARKET: COMPANY EVALUATION MATRIX, 2022
     10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 31 GLYCOMICS/GLYCOBIOLOGY MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
     10.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
             10.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
                        TABLE 330 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.7.2 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                        TABLE 331 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.7.3 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
                        TABLE 332 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.7.4 COMPETITIVE BENCHMARKING OF START-UPS/SMES
                        TABLE 333 GLYCOMICS/GLYCOBIOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
                        TABLE 334 GLYCOMICS/GLYCOBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
     10.8 COMPETITIVE SCENARIO AND TRENDS
             10.8.1 PRODUCT LAUNCHES
                        TABLE 335 GLYCOMICS/GLYCOBIOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2019–SEPTEMBER 2022
             10.8.2 DEALS
                        TABLE 336 GLYCOMICS/GLYCOBIOLOGY MARKET: DEALS, JANUARY 2019–SEPTEMBER 2022
             10.8.3 OTHER DEVELOPMENTS
                        TABLE 337 GLYCOMICS/GLYCOBIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2019– SEPTEMBER 2022

11 COMPANY PROFILES (Page No. - 256)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 MERCK KGAA
                        TABLE 338 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT
                        TABLE 339 MERCK KGAA: PRODUCT OFFERINGS
             11.1.2 THERMO FISHER SCIENTIFIC
                        TABLE 340 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
                        TABLE 341 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
             11.1.3 AGILENT TECHNOLOGIES
                        TABLE 342 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
                        FIGURE 34 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
                        TABLE 343 AGILENT TECHNOLOGIES: PRODUCT OFFERINGS
             11.1.4 WATERS CORPORATION
                        TABLE 344 WATERS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 35 WATERS CORPORATION: COMPANY SNAPSHOT
                        TABLE 345 WATERS CORPORATION: PRODUCT OFFERINGS
             11.1.5 NEW ENGLAND BIOLABS
                        TABLE 346 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
             11.1.6 TAKARA BIO
                        TABLE 347 TAKARA BIO: BUSINESS OVERVIEW
                        FIGURE 36 TAKARA BIO: COMPANY SNAPSHOT
                        TABLE 348 TAKARA BIO: PRODUCT OFFERINGS
             11.1.7 SHIMADZU CORPORATION
                        TABLE 349 SHIMADZU CORPORATION: BUSINESS OVERVIEW
                        FIGURE 37 SHIMADZU CORPORATION: COMPANY SNAPSHOT
                        TABLE 350 SHIMADZU CORPORATION: PRODUCT OFFERINGS
             11.1.8 DANAHER CORPORATION
                        TABLE 351 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT
                        TABLE 352 DANAHER CORPORATION: PRODUCT OFFERINGS
             11.1.9 BIO-TECHNE
                        TABLE 353 BIO-TECHNE: BUSINESS OVERVIEW
                        FIGURE 39 BIO-TECHNE: COMPANY SNAPSHOT
                        TABLE 354 BIO-TECHNE: PRODUCT OFFERINGS
             11.1.10 SUMITOMO BAKELITE
                        TABLE 355 SUMITOMO BAKELITE: BUSINESS OVERVIEW
                        FIGURE 40 SUMITOMO BAKELITE: COMPANY SNAPSHOT
                        TABLE 356 SUMITOMO BAKELITE: PRODUCT OFFERINGS
             11.1.11 BRUKER CORPORATION
                        TABLE 357 BRUKER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 41 BRUKER CORPORATION: COMPANY SNAPSHOT
                        TABLE 358 BRUKER CORPORATION: PRODUCT OFFERINGS
             11.1.12 LUDGER
                        TABLE 359 LUDGER: BUSINESS OVERVIEW
                        TABLE 360 LUDGER: PRODUCT OFFERINGS
             11.1.13 PROMEGA CORPORATION
                        TABLE 361 PROMEGA CORPORATION: BUSINESS OVERVIEW
                        TABLE 362 PROMEGA CORPORATION: PRODUCT OFFERINGS
             11.1.14 AMSBIO
                        TABLE 363 AMSBIO: BUSINESS OVERVIEW
                        TABLE 364 AMSBIO: PRODUCT OFFERINGS
             11.1.15 CD BIOGLYCO
                        TABLE 365 CD BIOGLYCO: BUSINESS OVERVIEW
                        TABLE 366 CD BIOGLYCO: PRODUCT OFFERINGS
             11.1.16 ICE S.P.A.
                        TABLE 367 ICE S.P.A.: BUSINESS OVERVIEW
                        TABLE 368 ICE S.P.A.: PRODUCT OFFERINGS
             11.1.17 ASPARIA GLYCOMICS
                        TABLE 369 ASPARIA GLYCOMICS: BUSINESS OVERVIEW
                        TABLE 370 ASPARIA GLYCOMICS: PRODUCT OFFERINGS
             11.1.18 LECTENZ BIO
                        TABLE 371 LECTENZ BIO: BUSINESS OVERVIEW
                        TABLE 372 LECTENZ BIO: PRODUCT OFFERINGS
             11.1.19 Z BIOTECH, LLC
                        TABLE 373 Z BIOTECH, LLC: BUSINESS OVERVIEW
                        TABLE 374 Z BIOTECH, LLC: PRODUCT OFFERINGS
             11.1.20 CHEMILY GLYCOSCIENCE
                        TABLE 375 CHEMILY GLYCOSCIENCE: BUSINESS OVERVIEWs
                        TABLE 376 CHEMILY GLYCOSCIENCE: PRODUCT OFFERINGS
     11.2 OTHER COMPANIES
             11.2.1 GLYCOMIX
             11.2.2 GLYCODIAG
             11.2.3 KODE BIOTECH LIMITED
             11.2.4 GLYXERA GMBH
             11.2.5 RAYBIOTECH LIFE

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 313)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 CUSTOMIZATION OPTIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the glycomics/glycobiology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the glycomics/glycobiology market. The secondary sources used for this study include Press Releases, Annual Reports, White Papers, Certified Publications, Articles form authorized authors, Gold Standard and Silver Standard Websites, Directories and Databases, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Glycomics/Glycobiology Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the glycomics/glycobiology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the glycomics/glycobiology and related products business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global glycomics/glycobiology market based on the product, application, end user, and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities).
  • To strategically analyse micromarkets with respect to individual growth trends, future prospects, and contributions to the overall glycomics/glycobiology market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as product launches, expansions, acquisitions, agreements, collaborations, and partnerships in the glycomics/glycobiology market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

  • An additional five company profiles
Report Code
BT 2776
Published ON
Nov, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Glycomics/ Glycobiology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback